Form 4: Cardio Diagnostics Holdings Director Wendy J. Betts Reports Stock Option Transaction
SEC Form 4 Filing
Director Wendy J. Betts of Cardio Diagnostics Holdings, Inc. reports acquiring stock options and disposing of derivative securities.
Summary
- On March 31, 2025, Wendy J. Betts, a director of Cardio Diagnostics Holdings, Inc., reported a transaction involving stock options.
- Betts acquired 18,939 stock options with an exercise price of $0.33.
- These options are exercisable from March 31, 2025, and expire on March 31, 2035.
- Betts also disposed of 21,211 derivative securities.
- Following the reported transactions, Betts beneficially owns derivative securities.
Sentiment
Score: 5
Explanation: This is a neutral report of a director's stock option transaction, with no inherent positive or negative sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and provides transparency to the market regarding the holdings and transactions of company directors.
Stakeholder Impact
- The transaction provides transparency to shareholders regarding director's holdings.
Key Dates
| Date | Description |
|---|---|
| 03/31/2025 | Date of earliest transaction: Acquisition of stock options and disposal of derivative securities. |
| 03/31/2025 | Stock options become exercisable. |
| 03/31/2035 | Expiration date of the stock options. |
| 04/01/2025 | Date of signature for the Form 4 filing. |
Keywords
Form 4, Cardio Diagnostics Holdings, Director, Stock Options, Beneficial Ownership, CDIO, Wendy J. Betts
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.